Xencor (XNCR) Treasury Shares (2018 - 2026)
Xencor's (XNCR) quarterly Treasury Shares came in at $2.4 million in Q1 2026, up 786.55% year-on-year from $269246.0 in Q1 2025, and up 20.47% on a QoQ basis from $2.0 million in Q4 2025.
Xencor (XNCR) Treasury Shares (2018 - 2026) Analysis & Trends
Xencor (XNCR) has 9 years of Treasury Shares data on file, last reported at $2.4 million in Q1 2026.
- On a quarterly basis, Treasury Shares rose 786.55% year-over-year to $2.4 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 786.55% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, up 11.07% from the prior year.
- Treasury Shares for Q1 2026 stood at $2.4 million, up from $2.0 million in the prior quarter.
- Over the last five years, Treasury Shares for XNCR reached as high as $2.4 million in Q1 2026 and fell as low as $269246.0 in Q1 2025.
- Historically, Treasury Shares has averaged $1.6 million across 5 years, with a median of $1.7 million in 2023.
- Across the five-year window, Treasury Shares slumped 84.27% in 2025 and jumped 786.55% in 2026, its largest moves.
- Year by year, Treasury Shares stood at $1.2 million in 2022, then climbed by 20.89% to $1.5 million in 2023, then increased by 19.71% to $1.8 million in 2024, then gained by 11.07% to $2.0 million in 2025, then rose by 20.47% to $2.4 million in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $2.4 million in Q1 2026, $2.0 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | 2.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.39 Mn |
| Mar 31, 2026 | 2.39 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 269,246.00 |
| Mar 31, 2025 | 269,246.00 |
| Dec 31, 2024 | 1.78 Mn |
| Dec 31, 2024 | 1.78 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Sep 30, 2024 | 1.75 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Jun 30, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 1.49 Mn |
| Dec 31, 2023 | 1.49 Mn |